Increased IL26 expression is observed in the malignant pleural effusion (MPE) and peripheral blood of lung cancer patients, and predicts poor patient survival in part by suppressing CD8 T-cell cytotoxicity [198]. The gene discussed is CD8A; the disease is lung carcinoma.